IL1RL1 and psoriasis: Considering that MCs constitutively express IL-33R, IL-33 is a potent MC activator, and IL-33 has been shown to play a critical regulatory role in psoriasis, we hypothesised that IL-33 could promote activation of MCs and thus regulate psoriasis development.